0001950047-23-000374.txt : 20230503 0001950047-23-000374.hdr.sgml : 20230503 20230503173045 ACCESSION NUMBER: 0001950047-23-000374 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 23885556 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: GREY MICHAEL G CENTRAL INDEX KEY: 0001240122 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O SGX PHARMACEUTICALS, INC. STREET 2: 10505 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 144 1 primary_doc.xml 144 0001240122 XXXXXXXX LIVE 0001759425 MIRUM PHARMACEUTICALS, INC. 001-38981 950 Tower Lane, Suite 1050 Foster City CA 94404 (650) 667-4085 MICHAEL GREY Director Common Morgan Stanley Smith Barney LLC

1 New York Plaza 38th Floor New York NY 10004

14608 409024.00 38030661 05/03/2023 NASD COMMON 05/03/2023 STOCK OPTIONS ISSUER N 14608 05/03/2023 Cash Y 05/03/2023 08/30/2022 /s/ Michael G Grey